Is the rate of progression to CD higher in patients with indeterminate colitis than in those with IBDU

The retrieved excerpts do not directly compare rates of progression to Crohn's disease between "indeterminate colitis" (a post-colectomy pathological diagnosis) and "IBD unclassified" (a pre-colectomy clinical diagnosis). The terms are used inconsistently across the excerpts, and no single study contrasts the two groups head-to-head. What is reported is that among patients labeled with indeterminate colitis, only a minority eventually develop Crohn's disease while the majority behave like ulcerative colitis, and reclassification to a definite diagnosis is common over time ^1,2. ^1–5

What is known: - A small minority of indeterminate colitis patients eventually develop Crohn's disease, while the majority behave like ulcerative colitis on follow-up and after pouch surgery. ¹ - In one cohort, 72.5% of indeterminate colitis patients received a definite diagnosis of Crohn's disease or ulcerative colitis during follow-up, with an 80% cumulative probability of reclassification at 8 years; Crohn's diagnosis was more likely with fever at onset, segmental endoscopic lesions, extra-intestinal complications, or current smoking. ² - When made carefully, the indeterminate colitis diagnosis is associated with a low incidence of conversion to Crohn's disease over the long term. ³ - Terminology differs: indeterminate colitis has been defined as a post-colectomy pathological diagnosis when definitive Crohn's/UC features are absent, whereas IBD unclassified is described separately in a case-control study. ^4,5

What is unknown / caveats: - Excerpts use 'indeterminate colitis' and 'IBD unclassified' with differing/overlapping definitions, so a clean comparison cannot be extracted - No excerpt reports a head-to-head comparison of progression-to-Crohn's rates between the two labels - Progression figures come from single-cohort/pathology series, not comparative studies - The evidence does not establish whether progression to Crohn's disease differs between indeterminate colitis and IBD unclassified.

## References

1. Talbot IC. Indeterminate colitis: a pathologist's view. Dig Liver Dis. 2005;37(9):713-5. PMID: 15919251.

2. Meucci G, Bortoli A, Riccioli FA, Girelli CM, Radaelli F, Rivolta R, Tatarella M. Frequency and clinical evolution of indeterminate colitis: a retrospective multi-centre study in northern Italy. GSMII (Gruppo di Studio per le Malattie Infiammatorie Intestinali). Eur J Gastroenterol Hepatol. 1999;11(8):909-13. PMID: 10514127.

3. Gramlich T, Delaney CP, Lynch AC, Remzi FH, Fazio VW. Pathological subgroups may predict complications but not late failure after ileal pouch-anal anastomosis for indeterminate colitis. Colorectal Dis. 2003;5(4):315-9. PMID: 12814408.

4. Lin J, Cao Q, Zhang J, Li Y, Shen B, Zhao Z, Chinnaiyan AM, Bronner MP. MicroRNA expression patterns in indeterminate inflammatory bowel disease. Mod Pathol. 2013;26(1):148-54. PMID: 22899284.

5. [No authors listed]. Clinical features of inflammatory bowel disease unclassified: a case-control study. BMC Gastroenterol. 2024;24(1):105. PMID: 38481157.

For educational use only, not a substitute for clinical judgement or medical advice. Consult qualified clinicians for diagnosis and treatment decisions. This tool may contain errors; use the flag button below to report inaccurate or harmful content.

---

_Draft, generated by the IBDology RAG and not yet clinician-reviewed. Answers are grounded in the retrieved literature listed above; a high faithfulness score means the answer matches its sources, not that the sources are correct._